Release of Olink® Analyze 3.1 streamlines proteomic analysis to connect data to biological insightGlobeNewsWire • 06/28/22
UK Biobank Pharma Proteomics Project publishes early results from its pioneering proteomics researchGlobeNewsWire • 06/21/22
Olink Holding AB publ Sponsored ADR (OLK) Surges 7.3%: Is This an Indication of Further Gains?Zacks Investment Research • 06/20/22
Erasmus Medical Center, Rotterdam is partnering with Olink to deepen understanding of disease progression and accelerate the development of novel therapiesGlobeNewsWire • 06/16/22
Ultima Genomics and Olink collaborate to develop solution for high-throughput proteomicsPRNewsWire • 06/08/22
Singular Genomics and Olink collaborate to enable Olink® Explore on the G4 Max Read™ sequencing kitsGlobeNewsWire • 06/07/22
Element Biosciences and Olink collaborate to enable Olink® Explore on the Element AVITI™ SystemGlobeNewsWire • 06/07/22
Olink Holding AB (publ) (OLK) CEO Jon Heimer on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/15/22
Olink Holding AB publ Sponsored ADR (OLK) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 05/12/22
University of Oxford adopts Olink technology to advance protein biomarker discovery and unravel mechanisms of diseaseGlobeNewsWire • 05/09/22
Report from the Annual General Meeting of Olink Holding AB (publ) on 7 April 2022GlobeNewsWire • 04/07/22
TATAA Biocenter partners with Olink to add high quality proteomics with unrivaled throughput to their multi-omics offeringGlobeNewsWire • 03/09/22
THE NOMINATION COMMITTEE'S PROPOSAL FOR ELECTION OF MEMBERS OF THE BOARD OF DIRECTORS OF OLINK HOLDING AB (PUBL)GlobeNewsWire • 03/07/22
Olink Holding AB (publ) (OLK) CEO Jon Heimer on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/14/22
Olink reports fourth quarter and full year 2021 financial results and provides outlook for 2022GlobeNewsWire • 02/14/22
Olink announces preliminary unaudited revenue for the fourth quarter and full year 2021GlobeNewsWire • 01/10/22
Olink participates in one of the largest proteomics studies enabling new treatment options for patients with heart failureGlobeNewsWire • 12/02/21
Olink® Explore 3072 high-throughput proteomics platform now available: Significantly expands Olink's protein library for biomarker discoveryGlobeNewsWire • 12/01/21
Melissa Amrein, at the University Hospital of Basel, Switzerland, is awarded the 2021 Novelties in Biomarkers prize at the Biomarkers of the Future Conference in Paris, FranceGlobeNewsWire • 11/29/21